Avita Medical’s product heals donors 30% faster

Company News

by Jessica Amir

Avita Medical (ASX:AVH) has advised its new randomised skin trial shows that its ReCell product has healed donors 30 per cent faster.

The regenerative medical company’s study was on 106 patients who received skin grafts.

It’s the company’s third positive clinical trial of late and it found superior wound healing and improved aesthetic appearance.

Avita Medical says its pleased the data shows its ReCell product, can be used to both reduce patient trauma and heal patients much quicker.

Shares in Avita Medical (ASX:AVH) are trading flat at 8 cent.
 

Jessica Amir

Finance News Network
Jessica is a senior finance journalist and presents bulletins including the Market Outlook, Market at Midday and Market Wrap. She also interviews ASX CEOs and leading fund managers. She joined FNN in January 2017 with over six years of broadcast journalism experience including with Sky News Business, ABC 1, ABC's The Business and ABC24. She’s also worked as a TV reporter for Prime 7 and WIN News. Jessica has worked in financial planning for over six years with leading wealth managers and in real estate.